Career Enhancement Program

项目总结 纽约大学黑色素瘤孢子职业增强计划(CEP)将为独立研究人员做好准备 翻译研究的职业是研究黑色素瘤。为了实现这一目标，CEP将选择、支持和 引导个人专注于成为黑色素瘤的领先翻译研究人员。The Director of the the CEP，纽约大学朗格尼健康(NYULH)皮肤科主任Seth Orlow博士有一个 在培训翻译科学家方面建立了成功的记录。纽约大学黑色素瘤孢子CEP将 通过提供经济资助和学术资助，为优秀候选人提供长达两年的支持 指导。这将使获奖者能够成功地进行与黑色素瘤有关的研究，以及 同时为进一步开展孢子内部的全面研究项目提供了坚实的基础。CEP 将通过招募和支持黑色素瘤翻译研究方面的人才培养和增长管道 有前途的初级或正在崛起的教员，以及更成熟的研究人员，有可能成为 经验丰富的独立调查人员专注于黑色素瘤的翻译研究。CEP将监控， 监督和指导为CEP选择的每个人，以确保调查员朝着 在黑色素瘤翻译研究方面成功的独立职业生涯，除了帮助获奖者 计划和协作，以建立实现这一目标所需的技能。CEP坚定地致力于 培训各级妇女和任职人数不足的少数族裔候选人从事独立职业 调查人员。对CEP获奖者有利的独特优势包括现有的正规课程 由纽约大学提供，这将导致翻译研究的理学硕士学位和大量的 在多个专业领域有成就的导师。CEP在主题上与纽约大学黑色素瘤保持一致 孢子公司的首要使命是使用个性化的生物标志物来优化黑色素瘤的临床治疗 患者，并与孢子的计划和项目高度整合。这一主题整合将 使CEP能够最大限度地提高获奖者的职业发展。

PROJECT SUMMARY The NYU Melanoma SPORE Career Enhancement Program (CEP) will prepare investigators for independent translational research careers to study melanoma. To accomplish this goal, the CEP will select, support, and guide individuals focused on becoming leading translational researchers in melanoma. The Director of the CEP, Dr. Seth Orlow, Chairman of the Department of Dermatology at NYU Langone Health (NYULH), has an established track record of success in training translational scientists. The NYU Melanoma SPORE CEP will support outstanding candidates for up to 2 full years by providing both financial assistance and academic guidance. This will enable awardees to establish successful investigations related to melanoma, and simultaneously provide a solid foundation to further develop full research projects within the SPORE. The CEP will nurture and grow the pipeline of talent in melanoma translational research by recruiting and supporting promising junior or rising faculty in addition to more established investigators with the potential to become accomplished independent investigators focused on melanoma translational research. The CEP will monitor, oversee, and mentor each individual chosen for the CEP to ensure the investigator’s progress towards a successful independent career in melanoma translational research, in addition to availing awardees to programs and collaborations to build the skills necessary to achieve this end. The CEP is strongly committed to training women and underrepresented minority candidates at all levels for careers as independent investigators. Unique strengths that will be beneficial to CEP awardees include existing formal coursework offered by NYU that leads to a Master of Science degree in translational research and a large pool of accomplished mentors across multiple specialties. The CEP is thematically aligned to the NYU Melanoma SPORE’s overarching mission to use personalized biomarkers to optimize clinical management of melanoma patients, and is highly integrated with the programs and projects of the SPORE. This thematic integration will enable the CEP to maximize the progress of the awardees careers.